These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

543 related articles for article (PubMed ID: 1665051)

  • 21. "Seronegative" anti-MUSK positive myasthenia gravis presenting during pregnancy.
    Terrero A; Ramírez-Rivera J
    Bol Asoc Med P R; 2006; 98(3):210-2. PubMed ID: 19610560
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Autoimmune disorders of neuromuscular transmission.
    Mahadeva B; Phillips LH; Juel VC
    Semin Neurol; 2008 Apr; 28(2):212-27. PubMed ID: 18351523
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis.
    Evoli A; Tonali PA; Padua L; Monaco ML; Scuderi F; Batocchi AP; Marino M; Bartoccioni E
    Brain; 2003 Oct; 126(Pt 10):2304-11. PubMed ID: 12821509
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Classification of myasthenia gravis based on autoantibody status.
    Suzuki S; Utsugisawa K; Nagane Y; Satoh T; Terayama Y; Suzuki N; Kuwana M
    Arch Neurol; 2007 Aug; 64(8):1121-4. PubMed ID: 17698702
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anti-MuSK patient antibodies disrupt the mouse neuromuscular junction.
    Cole RN; Reddel SW; Gervásio OL; Phillips WD
    Ann Neurol; 2008 Jun; 63(6):782-9. PubMed ID: 18384168
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A potential role for B-cell activating factor in the pathogenesis of autoimmune myasthenia gravis.
    Ragheb S; Lisak R; Lewis R; Van Stavern G; Gonzales F; Simon K
    Arch Neurol; 2008 Oct; 65(10):1358-62. PubMed ID: 18852352
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Three cases of myasthenia gravis from one family with variations in clinical features and serum antibodies.
    Chen Y; Wang W; Wei D; Yang L
    Neuromuscul Disord; 2012 Mar; 22(3):286-8. PubMed ID: 22082588
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acquired slow-channel syndrome: a form of myasthenia gravis with prolonged open time of the acetylcholine receptor channel.
    Wintzen AR; Plomp JJ; Molenaar PC; van Dijk JG; van Kempen GT; Vos RM; Wokke JH; Vincent A
    Ann Neurol; 1998 Oct; 44(4):657-64. PubMed ID: 9778265
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasma from myasthenia gravis patients reduces acetylcholine receptor agonist-induced Na+ flux into TE671 cell line.
    Lang B; Richardson G; Rees J; Vincent A; Newsom-Davis J
    J Neuroimmunol; 1988 Aug; 19(1-2):141-8. PubMed ID: 2456301
    [TBL] [Abstract][Full Text] [Related]  

  • 30. alpha-Bungarotoxin displacing antibody in myasthenia gravis.
    Barkas T; Simpson JA
    J Clin Lab Immunol; 1982 Nov; 9(2):113-7. PubMed ID: 7154056
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antibodies to AChR, MuSK and VGKC in a patient with myasthenia gravis and Morvan's syndrome.
    Díaz-Manera J; Rojas-García R; Gallardo E; Juárez C; Martínez-Domeño A; Martínez-Ramírez S; Dalmau J; Blesa R; Illa I
    Nat Clin Pract Neurol; 2007 Jul; 3(7):405-10. PubMed ID: 17611489
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Antibodies in myasthenia gravis].
    Eymard B
    Rev Neurol (Paris); 2009 Feb; 165(2):137-43. PubMed ID: 19162288
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multiple forms of anti-acetylcholine receptor antibody in myasthenia gravis.
    Mittag T; Massa T; Kornfeld P; Papatestas A; Bender A; Genkins G
    Muscle Nerve; 1981; 4(1):16-25. PubMed ID: 6164920
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enzyme-linked immunosorbent assay for antibody against the nicotinic acetylcholine receptor in human myasthenia gravis.
    Kawanami S; Tsuji R; Oda K
    Ann Neurol; 1984 Feb; 15(2):195-200. PubMed ID: 6367620
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cell-Based Versus Enzyme-Linked Immunosorbent Assay for the Detection of Acetylcholine Receptor Antibodies in Chinese Juvenile Myasthenia Gravis.
    Yan C; Li W; Song J; Feng X; Xi J; Lu J; Zhou S; Zhao C
    Pediatr Neurol; 2019 Sep; 98():74-79. PubMed ID: 31307830
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A lipid-associated acetylcholine receptor as an antigen in diagnosis of myasthenia gravis.
    Raimond F; Vernet-der-Garabedian B; Morel E
    Clin Exp Immunol; 1982 Feb; 47(2):345-50. PubMed ID: 7075027
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Passive transfer of seronegative myasthenia gravis to mice.
    Burges J; Vincent A; Molenaar PC; Newsom-Davis J; Peers C; Wray D
    Muscle Nerve; 1994 Dec; 17(12):1393-400. PubMed ID: 7969240
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acetylcholine receptor in myasthenia gravis: increased affinity for alpha-bungarotoxin.
    Elias SB; Appel SH
    Ann Neurol; 1978 Sep; 4(3):250-2. PubMed ID: 718136
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Radioimmunoassay of antibodies to acetylcholine receptor in serum of myasthenia gravis patients.
    Brenner T; Abramsky O; Lisak RP; Zweiman B; Tarrab-Hazdai R; Fuchs S
    Isr J Med Sci; 1978 Sep; 14(9):986-9. PubMed ID: 721428
    [No Abstract]   [Full Text] [Related]  

  • 40. Autoantibodies in different forms of myasthenia gravis and in the Lambert-Eaton syndrome.
    Vincent A
    Handb Clin Neurol; 2008; 91():213-27. PubMed ID: 18631844
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.